| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.72B | +24.2% |
| R&D Expense | $1.17B | +16.5% |
| SG&A Expense | $1.45B | +17.6% |
| Operating Income | -$38.0M | +93.4% |
| Pre-tax Income | $156.0M | +129.2% |
| Income Tax | $39.0M | +25.8% |
| Net Income | $123.0M | +122.0% |
| EPS (Basic) | $0.30 | +121.1% |
| EPS (Diluted) | $0.29 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.02B | +51.3% |
| Accounts Receivable | $732.0M | +37.3% |
| Current Assets | $7.39B | +32.0% |
| Total Assets | $12.85B | +18.5% |
| Current Liabilities | $4.44B | +30.1% |
| Total Liabilities | $5.04B | +25.1% |
| Stockholders' Equity | $7.80B | +14.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.13B | +27.4% |
| Capital Expenditures | $104.0M | -15.4% |
| Investing Cash Flow | -$444.0M | -29.8% |
| Financing Cash Flow | -$204.0M | +72.9% |
| Free Cash Flow | $2.03B | +30.8% |
| +120.4% |